Table 1 Characteristics of patients in malignant tumor group
Malignant tumor type | Count | Male | Age at biospy |
|---|---|---|---|
Thyroid cancer | 41 (23.56) | 13 (31.7) | 50 (39, 59) |
Lung cancer | 34 (19.54) | 24 (70.6) | 58 ± 13 |
Prostate cancer | 10 (5.75) | 10 (100) | 66 (60, 70) |
Gastric cancer | 10 (5.75) | 5 (50) | 61 (54, 67) |
Colorectal cancer | 10 (5.75) | 7 (70) | 56 (50, 63) |
Multiple myeloma | 9 (5.17) | 7 (77.8) | 63 (49, 69) |
Breast cancer | 7 (4.02) | 0 (0) | 62 (49, 67) |
Uterine cancer | 7 (4.02) | 0 (0) | 58 (56, 60) |
Leukaemia | 6 (3.45) | 2 (33.3) | 45 (34, 69) |
Bladder cancer | 5 (2.87) | 2 (40) | 64 (54, 72) |
Esophageal cancer | 5 (2.87) | 4 (80) | 58 (45, 61) |
Cervical cancer | 4 (2.30) | 4 (100) | 51 (46, 60) |
Lymphoma | 4 (2.30) | 2 (50) | 63 (49, 69) |
Renal cancer | 4 (2.30) | 3 (75) | 60 (50, 64) |
Liver cancer | 3 (1.72) | 3 (100) | 66 (59, 67) |
Ovarian cancer | 1 (0.57) | 0 (0) | 67 |
Brain cancer | 2 (1.15) | 1 (50) | 53, 58 |
Cholangiocarcinoma | 1 (0.57) | 1 (100) | 70 |
Pancreatic cancer | 1 (0.57) | 0 (0) | 33 |
Testicular seminoma | 1 (0.57) | 1 (100) | 46 |
Malignant teratoma | 1 (0.57) | 0 (0) | 52 |
Adrenal Cancer | 1 (0.57) | 1 (100) | 62 |
Myelodysplastic syndrome | 1 (0.57) | 1 (100) | 38 |
Small intestinal cancer | 1 (0.57) | 0 (0) | 68 |
Other | 5 (2.87) | 2 (40) | 46 (39, 67) |